EUVIMEDEUVIMED entdecken
Crossref

Osteoporosis treatment in Poland in 2026

Brygida Kwiatkowska

Rheumatology · 06.11.2026 · 64 (5) · 353-355

DOI: 10.5114/reum/242148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology, online erschienen am 06.11.2026. Verfasst von Brygida Kwiatkowska. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For years, osteoporosis has been discussed as a major public health challenge, primarily linked to the aging of populations, especially in highly developed countries. Today, with a broader perspective, a larger arsenal of medications, and a deeper understanding of the causes and risk factors of osteoporosis, it remains surprising that we still find ourselves calling for better diagnosis, more timely referrals, and prompt treatment. Although it should be self-evident that therapy ought to be initiated – ideally – before a serious complication such as a low-energy (fragility) fracture occurs. osteoporosis osteoporosis osteoporosis For years, osteoporosis has been discussed as a major public health challenge For years, osteoporosis has been discussed as a major public health challenge

Zitieren

APA

Kwiatkowska, B. (2026). Osteoporosis treatment in Poland in 2026. Rheumatology, 64(5), 353-355. https://doi.org/10.5114/reum/242148

Vancouver

Kwiatkowska B. Osteoporosis treatment in Poland in 2026. Rheumatology. 2026;64(5):353-355. doi:10.5114/reum/242148

BibTeX
@article{Kwiatkowska2026,
  author = {Kwiatkowska, Brygida},
  title = {Osteoporosis treatment in Poland in 2026},
  journal = {Rheumatology},
  year = {2026},
  volume = {64},
  number = {5},
  pages = {353--355},
  doi = {10.5114/reum/242148}
}
Kostenlos starten →